-
Product Insights
FAL Magmt – 10-16 Seven Hills Road Residential Development – New South Wales
Equip yourself with the essential tools needed to make informed and profitable decisions with our FAL Magmt - 10-16 Seven Hills Road Residential Development - New South Wales report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – AP-101
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry AP-101 Drug Details AP-101 (NI-204) is under development for the treatment of familial amyotrophic...
-
Sector Analysis
Home and Garden Retailing in Japan – Sector Overview, Market Size and Forecast to 2025
The research report provides both the historic and forecast market data of total retail sales, and the home market in Japan. It illustrates the data with charts, graphs and tables summarizing the value, with category details in home sector. The forecasts include the impact of COVID-19 on growth. The research report also reveals major retailers share in home sector with their price and market positioning in 2020. The report uses data from GlobalData’s Retail database showing the trends in the...
-
Sector Analysis
Amyotrophic Lateral Sclerosis (ALS) – Opportunity Analysis and Forecasts to 2029
Amyotrophic Lateral Sclerosis (ALS) is a motor neuron degenerative disease which affects both upper motor neurons (UMN) and lower motor neurons (LMN). It is a progressive disease, with patients becoming increasingly dependent on carers and physicians as time from onset increases, and ultimately, it is fatal. ALS can be split into two origins, hereditary - which is known as FALS (Familial ALS) or idiopathic - known as SALS (sporadic ALS). ALS current treatment includes only two disease-modifying drugs: Sanofi’s Rilutek...
-
Sector Analysis
Amyotrophic Lateral Sclerosis: Opportunity Analysis and Forecast to 2027
Amyotrophic Lateral Sclerosis (ALS) is a motor neuron degenerative disease which affects both upper motor neurons (UMN) and lower motor neurons (LMN). It is a progressive disease, with patients becoming increasingly dependent on carers and physicians as time from onset increases, and ultimately, it is fatal. ALS can be split into two origins, hereditary – which is known as FALS (Familial ALS) or idiopathic – known as SALS (sporadic ALS). Currently there are only two drugs on the market that...